PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
PAZ-ARES, Luis G, DE MARINIS, Filippo, CORRAL, Jesús, MELEMED, Symantha, JOHN, William, CHOUAKI, Nadia, ZIMMERMANN, Annamaria H, VISSEREN-GRUL, Carla, GRIDELLI, Cesare, DEDIU, Mircea, THOMAS, Michael, PUJOL, Jean-Louis, BIDOLI, Paolo, MOLINIER, Olivier, TARINI PRASAD SAHOO, LAACK, Eckart, RECK, Martin
Published in Journal of clinical oncology (10.08.2013)
Published in Journal of clinical oncology (10.08.2013)
Get full text
Journal Article
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Paz-Ares, Luis, Dr, de Marinis, Filippo, MD, Dediu, Mircea, MD, Thomas, Michael, Prof, Pujol, Jean-Louis, Prof, Bidoli, Paolo, MD, Molinier, Olivier, MD, Sahoo, Tarini Prasad, MD, Laack, Eckart, Prof, Reck, Martin, MD, Corral, Jesús, MD, Melemed, Symantha, PhD, John, William, MD, Chouaki, Nadia, MD, Zimmermann, Annamaria H, MS, Visseren-Grul, Carla, MD, Gridelli, Cesare, MD
Published in The lancet oncology (01.03.2012)
Published in The lancet oncology (01.03.2012)
Get full text
Journal Article
RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer
Nakagawa, Kazuhiko, Nadal, Ernest, Garon, Edward B, Nishio, Makoto, Seto, Takashi, Yamamoto, Nobuyuki, Park, Keunchil, Shih, Jin-Yuan, Paz-Ares, Luis, Frimodt-Moller, Bente, Zimmermann, Annamaria H, Wijayawardana, Sameera, Visseren-Grul, Carla, Reck, Martin
Published in Clinical cancer research (01.10.2021)
Published in Clinical cancer research (01.10.2021)
Get full text
Journal Article
Exposure‐response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy
Wit, Ronald, Powles, Thomas, Castellano, Daniel, Necchi, Andrea, Lee, Jae‐Lyun, Heijden, Michiel S., Matsubara, Nobuaki, Bamias, Aristotelis, Fléchon, Aude, Sternberg, Cora N., Drakaki, Alexandra, Yu, Evan Y., Zimmermann, Annamaria H., Long, Amanda, Walgren, Richard A., Gao, Ling, Bell‐McGuinn, Katherine M., Petrylak, Daniel P.
Published in British journal of clinical pharmacology (01.07.2022)
Published in British journal of clinical pharmacology (01.07.2022)
Get full text
Journal Article
PARAMOUNT: Descriptive Subgroup Analyses of Final Overall Survival for the Phase III Study of Maintenance Pemetrexed versus Placebo Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
Reck, Martin, Paz-Ares, Luis G., de Marinis, Filippo, Molinier, Olivier, Sahoo, Tarini Prasad, Laack, Eckart, John, William, Zimmermann, Annamaria H., Visseren-Grul, Carla, Gridelli, Cesare
Published in Journal of thoracic oncology (01.02.2014)
Published in Journal of thoracic oncology (01.02.2014)
Get full text
Journal Article
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy
Garon, Edward B, Scagliotti, Giorgio Vittorio, Gautschi, Oliver, Reck, Martin, Thomas, Michael, Iglesias Docampo, Lara, Kalofonos, Haralabos, Kim, Joo-Hang, Gans, Steven, Brustugun, Odd Terje, Orlov, Sergey V, Cuyun Carter, Gebra, Zimmermann, Annamaria H, Oton, Ana B, Alexandris, Ekaterine, Lee, Pablo, Wolff, Katharina, Stefaniak, Victoria Jennifer, Socinski, Mark A, Pérol, Maurice
Published in ESMO open (01.01.2020)
Published in ESMO open (01.01.2020)
Get full text
Journal Article
RELAY+: Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor ( EGFR )-mutated metastatic non-small cell lung cancer (NSCLC)
Nishio, Makoto, Nishio, Kazuto, Reck, Martin, Garon, Edward B., Imamura, Fumio, Kawaguchi, Tomoya, Yamaguchi, Hiroyuki, Ikeda, Satoshi, Hirano, Katsuya, Visseren-Grul, Carla M, Widau, Ryan C, Zimmermann, Annamaria H., Homma, Gosuke, Enatsu, Sotaro, Nakagawa, Kazuhiko
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abemaciclib combined with adjuvant endocrine therapy in patients with high risk early breast cancer who received neoadjuvant chemotherapy (NAC)
Martin, Miguel, Hegg, Roberto, Kim, Sung-Bae, Schenker, Michael, Grecea, Daniela, García-Sáenz, José A., Papazisis, Konstantinos, Ouyang, Quchang, Lacko, Aleksandra, Oksuzoglu, Berna, Reeves, James Andrew, Okera, Meena, Testa, Laura, Shimizu, Chikako, Wei, Ran, Forrester, Tammy D, Munoz, Maria, Zimmermann, Annamaria H., Headley, Desiree, Johnston, Stephen R. D.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
RELAY: A multinational, double-blind, randomized Phase 3 study of erlotinib (ERL) in combination with ramucirumab (RAM) or placebo (PL) in previously untreated patients with epidermal growth factor receptor mutation-positive (EGFRm) metastatic non-small cell lung cancer (NSCLC)
Nakagawa, Kazuhiko, Garon, Edward B., Seto, Takashi, Nishio, Makoto, Ponce Aix, Santiago, Chiu, Chao-Hua, Park, Keunchil, Novello, Silvia, Nadal, Ernest, Imamura, Fumio, Yoh, Kiyotaka, Shih, Jin-Yuan, Au, Kwok Hung, Moro-Sibilot, Denis, Enatsu, Sotaro, Zimmermann, Annamaria H., Frimodt-Moller, Bente, Visseren Grul, Carla M., Reck, Martin
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Ramucirumab (RAM) exposure-response (ER) relationship in RANGE: A randomized phase III trial of RAM plus docetaxel (DOC) versus placebo (P) plus DOC in advanced platinum-refractory urothelial carcinoma (UC) patients (pts)
De Wit, Ronald, Powles, Thomas, Castellano, Daniel E., Necchi, Andrea, Lee, Jae-Lyun, Van Der Heijden, Michiel Simon, Matsubara, Nobuaki, Bamias, Aristotelis, Flechon, Aude, Sternberg, Cora N., Drakaki, Alexandra, Yu, Evan Y., Hamid, Oday, Zimmermann, Annamaria H., Gao, Ling, Long, Amanda, Walgren, Richard A., Bell-McGuinn, Katherine M, Petrylak, Daniel Peter
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial
Drakaki, Alexandra, Kirby, Conor J., van der Heijden, Michiel S., Petrylak, Daniel P., Powles, Thomas, Chi, Kim N., Fléchon, Aude, Necchi, Andrea, Géczi, Lajos, Lee, Jae-Lyun, Gakis, Georgios, Bracarda, Sergio, Chowdhury, Simon, Lin, Chia-Chi, Keizman, Daniel, Vaishampayan, Ulka N., Zimmermann, Annamaria H., Bell-McGuinn, Katherine, Castellano, Daniel
Published in Bladder cancer (01.01.2020)
Published in Bladder cancer (01.01.2020)
Get full text
Journal Article